Similar articles

• Second-generation everolimus-eluting stents and the beat goes on?

  Kutcher MA. Kutcher MA. JACC Cardiovasc Interv. 2011 Nov;4(11):1216-7. doi: 10.1016/j.jcin.2011.09.003. JACC Cardiovasc Interv. 2011. PMID: 22115662 No abstract available.
• Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent.

  Onuma Y, Serruys PW, Gomez J, de Bruyne B, Dudek D, Thuesen L, Smits P, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Garcia-Garcia H, Ormiston JA; ABSORB Cohort A and B investigators. Onuma Y, et al. Catheter Cardiovasc Interv. 2011 Jul 1;78(1):3-12. doi: 10.1002/ccd.22864. Epub 2011 Mar 16. Catheter Cardiovasc Interv. 2011. PMID: 21413120 Clinical Trial.
• Drug-coated balloon after coronary stenting falls short.

  Belardi JA, Albertal M. Belardi JA, et al. Catheter Cardiovasc Interv. 2014 Aug 1;84(2):332-3. doi: 10.1002/ccd.25575. Catheter Cardiovasc Interv. 2014. PMID: 25045099 No abstract available.
• Everolimus-eluting bioabsorbable stent--Abbot Vascular programme.

  Onuma Y, Piazza N, Ormiston JA, Serruys PW. Onuma Y, et al. EuroIntervention. 2009 Dec 15;5 Suppl F:F98-F102. doi: 10.4244/EIJV5IFA17. EuroIntervention. 2009. PMID: 22100687 Review. No abstract available.
• Bioabsorbable coronary stents.

  Ormiston JA, Serruys PW. Ormiston JA, et al. Circ Cardiovasc Interv. 2009 Jun;2(3):255-60. doi: 10.1161/CIRCINTERVENTIONS.109.859173. Circ Cardiovasc Interv. 2009. PMID: 20031723 Review. No abstract available.